Something unexpected is making a splash at one of New Braunfels’ most anticipated spring events. Before the first cardboard boat even hits the water, attendees are already seeing the impact. The City ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

According to @godofprompt, recursive prompting is an AI technique where system outputs are fed back in as inputs to refine solutions through multiple iterations (source: @godofprompt, Dec 16, 2025).

A cinematic obsessive with the filmic palate of a starving raccoon, Rob London will watch pretty much anything once. With a mind like a steel trap, he's an endless fount of movie and TV trivia, borne ...

Amidst the AI boom transforming various sectors, Recursion Pharmaceuticals (NASDAQ: RXRX), a previously beaten-down AI-biotech, is showing signs of a rebound. Its stock has skyrocketed 25% in the past ...

SpaceX teased the next-generation vehicle that could reach the moon and Mars during its live webcast of a Starship mission known as flight 11. Starship is regarded as the world's largest and most ...

There's a problem in the job market, but if you don't dig below the surface in the latest monthly employment report, you might not see it. The overall unemployment rate is 4.3% and in the last year it ...

Creating simple data classes in Java traditionally required substantial boilerplate code. Consider how we would represent Java’s mascots, Duke and Juggy: public class JavaMascot { private final String ...

The dessert-stuffed Dubai chocolate bar, of viral TikTok fame, has seen many imitators. Its chocolate snap and pistachio-pastry crunch has inspired everything from milkshakes to croissants. Now, Hong ...

Sept 2 (Reuters) - Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Q2 2025 Earnings Call Transcript August 5, 2025 Recursion Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.41187 EPS, ...